Response to Pham et al., "More data are needed to confirm the utility of screening for atypical fibroxanthoma and pleomorphic dermal sarcoma recurrence"
Research output: Contribution to journal › Comment/debate › Research › peer-review
To the Editor: We thank Pham et al1 for their interest in our study on patients with atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS),2 and we appreciate the opportunity to discuss and clarify our analysis further.
| Original language | English |
|---|---|
| Journal | Journal of the American Academy of Dermatology |
| Volume | 90 |
| Issue number | 5 |
| Pages (from-to) | e175-e176 |
| Number of pages | 2 |
| ISSN | 0190-9622 |
| DOIs |
|
| Publication status | Published - 2024 |
ID: 385888993